High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.

Prediletto, Irene; Farag, Sarah Ahmed Ibrahim; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bregy, Rachel; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst Müller, Thomas Niklaus (2019). High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients. (In Press). Bone marrow transplantation Nature Publishing Group 10.1038/s41409-019-0508-2

[img] Text
s41409-019-0508-2.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (396kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Prediletto, Irene; Farag, Sarah Ahmed Ibrahim; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bregy, Rachel; Novak, Urban and Pabst Müller, Thomas Niklaus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0268-3369

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Pierrette Durand Lüthi

Date Deposited:

12 Sep 2019 12:06

Last Modified:

24 Oct 2019 08:37

Publisher DOI:

10.1038/s41409-019-0508-2

PubMed ID:

30890768

BORIS DOI:

10.7892/boris.133102

URI:

https://boris.unibe.ch/id/eprint/133102

Actions (login required)

Edit item Edit item
Provide Feedback